Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.
Pharmacokinetics
beta‐adrenergic blocking agents
metoprolol
personalized medicine
pharmacology
propranolol
Journal
Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
12
11
2018
revised:
25
04
2019
accepted:
22
05
2019
entrez:
25
7
2019
pubmed:
25
7
2019
medline:
30
4
2020
Statut:
epublish
Résumé
The aim of this study was to evaluate the pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology by reviewing single-dose and steady-state pharmacokinetic studies from the literature. PubMed was searched for pharmacokinetic studies of beta-adrenergic blocking agents, both single-dose and steady-state studies. The studies included reported maximum plasma concentration (C
Identifiants
pubmed: 31338197
doi: 10.1002/prp2.496
pii: PRP2496
pmc: PMC6624454
doi:
Substances chimiques
Adrenergic beta-Antagonists
0
Carvedilol
0K47UL67F2
Propranolol
9Y8NXQ24VQ
Metoprolol
GEB06NHM23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00496Déclaration de conflit d'intérêts
There are no competing interests to declare.
Références
Hypertens Res. 2012 Mar;35(3):245-50
pubmed: 22089536
Clin Pharmacol Ther. 2004 Dec;76(6):536-44
pubmed: 15592325
J Clin Hypertens (Greenwich). 2011 Sep;13(9):649-53
pubmed: 21896144
J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):310-9
pubmed: 23637119
Clin Pharmacokinet. 2002;41(7):505-16
pubmed: 12083978
Clin Pharmacol Ther. 1981 Dec;30(6):790-5
pubmed: 7307427
Lancet. 1993 Apr 10;341(8850):967-8
pubmed: 8096308
Clin Pharmacol Ther. 2013 Sep;94(3):394-9
pubmed: 23665868
Am J Cardiol. 1997 Nov 13;80(9B):15J-19J
pubmed: 9375944
Clin Pharmacol Ther. 2005 Oct;78(4):378-87
pubmed: 16198657
Arzneimittelforschung. 2003;53(12):814-22
pubmed: 14732961
Am Heart J. 1979 Aug;98(2):256-62
pubmed: 36744
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Clin Res Cardiol. 2018 Nov;107(11):1040-1049
pubmed: 29774407
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182
pubmed: 28329228
J Pharm Sci. 2008 Feb;97(2):654-90
pubmed: 17630642
N Engl J Med. 1996 May 23;334(21):1349-55
pubmed: 8614419
Curr Clin Pharmacol. 2006 Jan;1(1):35-46
pubmed: 18666376
J Am Coll Cardiol. 2018 Apr 17;71(15):1663-1671
pubmed: 29650123
Heart Fail Rev. 2004 Apr;9(2):131-7
pubmed: 15516861
Eur Heart J. 2015 Nov 1;36(41):2793-2867
pubmed: 26320108
Eur J Clin Pharmacol. 1979 Nov;16(5):327-30
pubmed: 520399
Pharmacogenomics. 2016 Nov;17(16):1817-1858
pubmed: 27813451
Clin Pharmacol Ther. 2004 Oct;76(4):302-12
pubmed: 15470329
J Atr Fibrillation. 2014 Feb 28;6(5):978
pubmed: 27957038
Pharmacol Res Perspect. 2019 Jul 12;7(4):e00496
pubmed: 31338197
Ann Intern Med. 2001 Apr 3;134(7):550-60
pubmed: 11281737
Br J Pharmacol Chemother. 1965 Dec;25(3):577-91
pubmed: 4380598
Am Heart J. 1984 Oct;108(4 Pt 2):1070-7
pubmed: 6148865
Clin Pharmacol Ther. 1977 Jul;22(1):108-12
pubmed: 872491
Br J Clin Pharmacol. 1979 Jan;7(1):49-54
pubmed: 760742
Eur J Clin Pharmacol. 1993;45(2):161-3
pubmed: 8223839
Am Heart J. 1982 Aug;104(2 Pt 2):364-73
pubmed: 6125095